Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Richard J Lin, MD PhD, Theresa A Elko, MS, Patrick Hilden, MS, Parastoo B. Dahi, MD, Ann A. Jakubowski, MD PhD, Miguel-Angel Perales, MD, Juliet Barker, MBBS, H.R. Castro-Malaspina, MD, Brian C. Shaffer, MD, Armin Shahrokni, MD, Roni Tamari, MD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2018-99-113876

Published: 2018

Journal Articles

Pre-Salvage ISS and Other Important Outcome Predictors in CD34 Selected Allogeneic Hematopoietic Cell Transplant for Multiple Myeloma

Adam Bryant, MD MSc, Patrick Hilden, MS, Sergio Giralt, MD, Miguel-Angel Perales, MD, Guenther Koehne, MD PhD

Blood (2018) 132 (Supplement 1): 3473.

https://doi.org/10.1182/blood-2018-99-118625

Published: 2018

Journal Articles

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Nicole Pearl, PharmD, Andrew Lin, PharmD, BCOP, Patrick Hilden, MS, Larry W Buie, PharmD, BCOP, FASHP, Kevin Robinson, Molly Maloy, MS, Gunjan L. Shah, MD

Blood (2018) 132 (Supplement 1): 4617.

https://doi.org/10.1182/blood-2018-99-119554

Published: 2018

Journal Articles

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Parastoo B. Dahi, MD, Chikaodi Obioha, Sheila Kenny, NP, Patrick Hilden, MS, Molly Maloy, MS, Alexander Geyer, MD, Wendy Schaffer, MD, Roni Tamari, MD, Craig S. Sauter, MD, Ann A. Jakubowski, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2018-99-112632

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation Overcomes the Negative Prognostic Impact of TP53 Alterations in Mantle Cell Lymphoma

Richard J Lin, MDPhD, Caleb Ho, MD, Patrick Hilden, MS, Juliet Barker, MBBS, Sergio Giralt, MD, Paul A. Hamlin, MD, Ann A. Jakubowski, MDPhD, H.R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD

Blood (2018) 132 (Supplement 1): 4668.

https://doi.org/10.1182/blood-2018-99-113186

Published: 2018

Journal Articles

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Blood (2018) 132 (Supplement 1): 2258.

https://doi.org/10.1182/blood-2018-99-120049

Published: 2018

Journal Articles

The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Miriam Sanchez-Escamilla, Patrick Hilden, MS, Molly Maloy, MS, Samira A Fatmi, BS, Doris Ponce, MD, Craig S. Sauter, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD

Blood (2018) 132 (Supplement 1): 2069.

https://doi.org/10.1182/blood-2018-99-111036

Published: 2018

Journal Articles

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Roni Tamari, MD, Christina Cho, MD, Patrick Hilden, MS, Taylor Borrill, BA, CCRP, Molly Maloy, MS, H.R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Genovefa Papanicolaou, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3319.

https://doi.org/10.1182/blood.V130.Suppl_1.3319.3319

Published: 2017

Journal Articles

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Andrew Lin, PharmD, Patrick Hilden, MS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Roni Tamari, MD, Doris Ponce, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD

Blood (2017) 130 (Supplement 1): 3255.

https://doi.org/10.1182/blood.V130.Suppl_1.3255.3255

Published: 2017

Journal Articles

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Jeremy Pappacena, PharmD, Valkal Bhatt, PharmD, BCOP, BCPS, Gunjan L. Shah, MD, Patrick Hilden, MS, Molly Maloy, MS, Larry W Buie, PharmD, BCOP, FASHP, Sergio A. Giralt, MD, Michael Scordo, MD

Blood (2017) 130 (Supplement 1): 1950.

https://doi.org/10.1182/blood.V130.Suppl_1.1950.1950

Published: 2017

Journal Articles

MYC-Dependent PI3K and MCL-1 Feedbacks Attenuate BET Inhibitors Activity in Diffuse Large B-Cell Lymphoma

Enrico Derenzini, MD PhD, Patrizia Mondello, MD MSc, Yuxuan Liu, PhD, Mary Scallion, Zahra Asgari, John Philip, Patrick Hilden, MS, Hakim Djaballah, PhD, Ouathek Ouerfelli, PhD, Elisa de Stanchina, PhD, Venkatraman Seshan, PhD, Ronald Hendrickson, PhD, Andrew D. Zelenetz, Anas Younes, MD

Blood (2016) 128 (22): 294.

https://doi.org/10.1182/blood.V128.22.294.294

Published: 2016

Journal Articles

Prognostic Factors of CLL Patients Undergoing Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in the Immunochemotherapy Era

Oscar B. Lahoud, MD, Patrick Hilden, MS, Molly A. Maloy, MS, Parastoo B. Dahi, MD, Hugo Castro-Malaspina, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Craig S. Sauter, MD

Blood (2016) 128 (22): 5865.

https://doi.org/10.1182/blood.V128.22.5865.5865

Published: 2016

Journal Articles

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Christina Cho, MD, Patrick Hilden, MS, Jonathan U. Peled, MD PhD, Scott T. Avecilla, MD PhD, Pere Barba, MD, Juliet N. Barker, MBBS (Hons), Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Guenther Koehne, MD PhD, Richard C. Meagher, PhD, Molly A. Maloy, MS, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Doris M. Ponce, MD, Marcel R. M. van den Brink, MD PhD, James W. Young, MD, Miguel-Angel Perales, MD

Blood (2016) 128 (22): 3498.

https://doi.org/10.1182/blood.V128.22.3498.3498

Published: 2016

Journal Articles

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Poppiti, PharmD, Andrew Lin, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Patrick Hilden, MS, Hugo Castro-Malaspina, MD

Blood (2016) 128 (22): 4623.

https://doi.org/10.1182/blood.V128.22.4623.4623

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Bartlomiej Getta, MBBS,, Ashwin Kishtagari, MD, Patrick Hilden, MS, Sean Devlin, PhD, Molly A. Maloy, MS, Patrick K. Gonzales, Brian C. Shaffer, MD, Doris M Ponce, MD, Boglarka Gyurkocza, MD, Juliet N. Barker, MBBS, Esperanza B. Papadopoulos, MD, Hugo Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, James W. Young, MD, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Virginia M. Klimek, MD

Blood (2016) 128 (22): 3188.

https://doi.org/10.1182/blood.V128.22.3188.3188

Published: 2016

Journal Articles

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Tim J Peterson, PharmD, Andrew Lin, PharmD, BCOP, Patrick Hilden, MS, Sean Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Jae H Park, MD

Blood (2015) 126 (23): 1290.

https://doi.org/10.1182/blood.V126.23.1290.1290

Published: 2015

Journal Articles

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Blood (2015) 126 (23): 4332.

https://doi.org/10.1182/blood.V126.23.4332.4332

Published: 2015

Journal Articles

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Blood (2015) 126 (23): 3231.

https://doi.org/10.1182/blood.V126.23.3231.3231

Published: 2015

Journal Articles

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma

Craig S. Sauter, Matthew J. Matasar, Jessica Meikle, Heiko Schoder, Gary A. Ulaner, Jocelyn C. Migliacci, Patrick Hilden, Sean M. Devlin, Andrew D. Zelenetz, Craig H. Moskowitz

Blood (2015) 125 (16): 2579–2581.

https://doi.org/10.1182/blood-2014-10-606939

Published: 2015

Journal Articles

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

Blood (2015) 125 (1): 199–205.

https://doi.org/10.1182/blood-2014-06-584789

Published: 2015

Includes: Supplemental data

NARROW

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Pre-Salvage ISS and Other Important Outcome Predictors in CD34 Selected Allogeneic Hematopoietic Cell Transplant for Multiple Myeloma

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Allogeneic Stem Cell Transplantation Overcomes the Negative Prognostic Impact of TP53 Alterations in Mantle Cell Lymphoma

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

MYC-Dependent PI3K and MCL-1 Feedbacks Attenuate BET Inhibitors Activity in Diffuse Large B-Cell Lymphoma

Prognostic Factors of CLL Patients Undergoing Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in the Immunochemotherapy Era

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only